Could This New Development Soon Buoy Eli Lilly and Novo Nordisk Stock?
Lilly(US:LLY) The Motley Fool·2024-04-07 11:15New findings could lead to more growth from their prized medicines.As two of the most-watched and fastest-growing big pharma companies, Novo Nordisk (NVO 1.53%) and Eli Lilly (LLY 2.10%) already have upwardly mobile stock prices.And now, there's yet another piece of news that could presage even more growth over the long term. Let's explore this new development. This clinical trial could pave the way for even larger marketsNovo Nordisk's blockbuster drug Ozempic is widely known for being effective at control ...